These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


437 related items for PubMed ID: 17304102

  • 1. CD14-159 C allele is associated with increased risk of mortality after burn injury.
    Barber RC, Aragaki CC, Chang LY, Purdue GF, Hunt JL, Arnoldo BD, Horton JW.
    Shock; 2007 Mar; 27(3):232-7. PubMed ID: 17304102
    [Abstract] [Full Text] [Related]

  • 2. Association of mitochondrial allele 4216C with increased risk for sepsis-related organ dysfunction and shock after burn injury.
    Huebinger RM, Gomez R, McGee D, Chang LY, Bender JE, O'Keeffe T, Burris AM, Friese SM, Purdue GF, Hunt JL, Arnoldo BD, Horton JW, Barber RC.
    Shock; 2010 Jan; 33(1):19-23. PubMed ID: 19487983
    [Abstract] [Full Text] [Related]

  • 3. Association of mitochondrial allele 4216C with increased risk for complicated sepsis and death after traumatic injury.
    Gomez R, O'Keeffe T, Chang LY, Huebinger RM, Minei JP, Barber RC.
    J Trauma; 2009 Mar; 66(3):850-7; discussion 857-8. PubMed ID: 19276764
    [Abstract] [Full Text] [Related]

  • 4. Influence of CD14 polymorphism on CD14 expression in patients with extensive burns.
    Lin J, Yao YM, Dong N, Chai JK, Yu Y, Hou XX, Zhu JM, Sheng ZY.
    Burns; 2009 May; 35(3):365-71. PubMed ID: 18951711
    [Abstract] [Full Text] [Related]

  • 5. TLR4 and TNF-alpha polymorphisms are associated with an increased risk for severe sepsis following burn injury.
    Barber RC, Aragaki CC, Rivera-Chavez FA, Purdue GF, Hunt JL, Horton JW.
    J Med Genet; 2004 Nov; 41(11):808-13. PubMed ID: 15520404
    [Abstract] [Full Text] [Related]

  • 6. The -260 C-->T promoter polymorphism of the lipopolysaccharide receptor CD14 and severe sepsis in trauma patients.
    Heesen M, Bloemeke B, Schade U, Obertacke U, Majetschak M.
    Intensive Care Med; 2002 Aug; 28(8):1161-3. PubMed ID: 12185442
    [Abstract] [Full Text] [Related]

  • 7. Combining early coagulation and inflammatory status improves prediction of mortality in burned and nonburned trauma patients.
    Park MS, Salinas J, Wade CE, Wang J, Martini W, Pusateri AE, Merrill GA, Chung K, Wolf SE, Holcomb JB.
    J Trauma; 2008 Feb; 64(2 Suppl):S188-94. PubMed ID: 18376164
    [Abstract] [Full Text] [Related]

  • 8. Impact of genetic variants of CD14 and TLR4 on subgingival periodontopathogens.
    Schulz S, Zissler N, Altermann W, Klapproth J, Zimmermann U, Gläser C, Schaller HG, Reichert S.
    Int J Immunogenet; 2008 Dec; 35(6):457-64. PubMed ID: 19046305
    [Abstract] [Full Text] [Related]

  • 9. Common TNF-alpha, IL-1 beta, PAI-1, uPA, CD14 and TLR4 polymorphisms are not associated with disease severity or outcome from Gram negative sepsis.
    Jessen KM, Lindboe SB, Petersen AL, Eugen-Olsen J, Benfield T.
    BMC Infect Dis; 2007 Sep 18; 7():108. PubMed ID: 17877801
    [Abstract] [Full Text] [Related]

  • 10. Functional significance of CD14 promoter polymorphisms and their clinical relevance in a Chinese Han population.
    Gu W, Dong H, Jiang DP, Zhou J, Du DY, Gao JM, Yao YZ, Zhang LY, Wen AQ, Liu Q, Wang ZG, Jiang JX.
    Crit Care Med; 2008 Aug 18; 36(8):2274-80. PubMed ID: 18596635
    [Abstract] [Full Text] [Related]

  • 11. Genetic polymorphisms of CD14 and Toll-like receptor-2 (TLR2) in patients with ulcerative colitis.
    Wang F, Tahara T, Arisawa T, Shibata T, Nakamura M, Fujita H, Iwata M, Kamiya Y, Nagasaka M, Takahama K, Watanabe M, Hirata I, Nakano H.
    J Gastroenterol Hepatol; 2007 Jun 18; 22(6):925-9. PubMed ID: 17565650
    [Abstract] [Full Text] [Related]

  • 12. Promoter polymorphism of the CD14 endotoxin receptor gene as a risk factor for alcoholic liver disease.
    Järveläinen HA, Orpana A, Perola M, Savolainen VT, Karhunen PJ, Lindros KO.
    Hepatology; 2001 May 18; 33(5):1148-53. PubMed ID: 11343243
    [Abstract] [Full Text] [Related]

  • 13. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
    Brunekreef B, Beelen R, Hoek G, Schouten L, Bausch-Goldbohm S, Fischer P, Armstrong B, Hughes E, Jerrett M, van den Brandt P.
    Res Rep Health Eff Inst; 2009 Mar 18; (139):5-71; discussion 73-89. PubMed ID: 19554969
    [Abstract] [Full Text] [Related]

  • 14. 159C>T CD14 genotype--functional effects on innate immune responses in term neonates.
    Härtel C, Rupp J, Hoegemann A, Bohler A, Spiegler J, von Otte S, Röder K, Schultz C, Göpel W.
    Hum Immunol; 2008 Jun 18; 69(6):338-43. PubMed ID: 18571004
    [Abstract] [Full Text] [Related]

  • 15. Molecular or pharmacologic inhibition of the CD14 signaling pathway protects against burn-related myocardial inflammation and dysfunction.
    Barber RC, Maass DL, White DJ, Chang LY, Horton JW.
    Shock; 2008 Dec 18; 30(6):705-13. PubMed ID: 18461018
    [Abstract] [Full Text] [Related]

  • 16. Effects of CD14-159 C/T polymorphism on CD14 expression and the balance between proinflammatory and anti-inflammatory cytokines in whole blood culture.
    Lin J, Yao YM, Yu Y, Chai JK, Huang ZH, Dong N, Sheng ZY.
    Shock; 2007 Aug 18; 28(2):148-53. PubMed ID: 17515856
    [Abstract] [Full Text] [Related]

  • 17. Mortality risk and length of stay associated with self-inflicted burn injury: evidence from a national sample of 30,382 adult patients.
    Thombs BD, Bresnick MG.
    Crit Care Med; 2008 Jan 18; 36(1):118-25. PubMed ID: 18090371
    [Abstract] [Full Text] [Related]

  • 18. Polymorphism in the promoter region of the CD14 gene and susceptibility to Brucellosis.
    Haidari M, Hajilooi M, Rezazadeh M, Rafiei A, Alavi SA, Keramat F.
    Immunol Invest; 2006 Jan 18; 35(2):239-45. PubMed ID: 16698680
    [Abstract] [Full Text] [Related]

  • 19. Role of CD14 promoter polymorphisms in Helicobacter pylori infection--related gastric carcinoma.
    Zhao D, Sun T, Zhang X, Guo Y, Yu D, Yang M, Tan W, Wang G, Lin D.
    Clin Cancer Res; 2007 Apr 15; 13(8):2362-8. PubMed ID: 17438094
    [Abstract] [Full Text] [Related]

  • 20. Synergistic effect of Toll-like receptor 4 and CD14 polymorphisms on the total atherosclerosis burden in patients with peripheral arterial disease.
    Vainas T, Stassen FR, Bruggeman CA, Welten RJ, van den Akker LH, Kitslaar PJ, Peña AS, Morré SA.
    J Vasc Surg; 2006 Aug 15; 44(2):326-32. PubMed ID: 16890863
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 22.